 Moneycontrol.com | AstraZeneca launches heart drug 'Brilinta' in India Economic Times NEW DELHI: AstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval from the Drug Controller General of India (DCGI). Based on the New Drug Advisory Committee's (NDAC) ... AstraZeneca launches its patented life-saving heart drug Brilinta in India AstraZeneca launches antiplatelet drug |
